Cite
HARVARD Citation
Amano, M. et al. (2022). Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan. Journal of infectious diseases. pp. 2038-2039. [Online].